David D. Meek - Net Worth and Insider Trading

David D. Meek Net Worth

The estimated net worth of David D. Meek is at least $4 Million dollars as of 2024-05-12. David D. Meek is the CEO of Mirati Therapeutics Inc and owns about 61,792 shares of Mirati Therapeutics Inc (MRTX) stock worth over $4 Million. David D. Meek is the Director of uniQure NV and owns about 22,481 shares of uniQure NV (QURE) stock worth over $110,607. David D. Meek is also the Chief Commercial Officer of Endocyte Inc and owns about 0 shares of Endocyte Inc (ECYT) stock worth over $0. Details can be seen in David D. Meek's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David D. Meek has not made any transactions after 2023-06-16 and currently still holds the listed stock(s).

Transaction Summary of David D. Meek

To

David D. Meek Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David D. Meek owns 6 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) , uniQure NV (QURE) , and Baxalta Inc (BXLT) among others .

Click here to see the complete history of David D. Meek’s form 4 insider trades.

Insider Ownership Summary of David D. Meek

Ticker Comapny Transaction Date Type of Owner
ETTX Entasis Therapeutics Holdings Inc 2019-06-19 director
QURE uniQure NV 2023-06-16 director
BXLT Baxalta Inc 2016-06-03 EVP and President & Oncology
2014-02-06 Chief Commercial Officer
2023-01-17 director & Chief Executive Officer
2023-10-16 director

David D. Meek Latest Holdings Summary

David D. Meek currently owns a total of 3 stocks. Among these stocks, David D. Meek owns 61,792 shares of Mirati Therapeutics Inc (MRTX) as of January 17, 2023, with a value of $4 Million and a weighting of 97.04%. David D. Meek owns 22,481 shares of uniQure NV (QURE) as of June 16, 2023, with a value of $110,607 and a weighting of 2.96%. David D. Meek also owns 0 shares of Endocyte Inc (ECYT) as of September 12, 2013, with a value of $0 and a weighting of 0%.

Latest Holdings of David D. Meek

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRTX Mirati Therapeutics Inc 2023-01-17 61,792 58.70 3,627,190
QURE uniQure NV 2023-06-16 22,481 4.92 110,607
ECYT Endocyte Inc 2013-09-12 0 23.99 0

Holding Weightings of David D. Meek


David D. Meek Form 4 Trading Tracker

According to the SEC Form 4 filings, David D. Meek has made a total of 2 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 3,179 shares on January 17, 2023, which brought David D. Meek around $134,726.

According to the SEC Form 4 filings, David D. Meek has made a total of 4 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in uniQure NV is the sale of 2,290 shares on June 16, 2023, which brought David D. Meek around $43,167.

According to the SEC Form 4 filings, David D. Meek has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 10,000 shares on September 12, 2013, which brought David D. Meek around $155,000.

Insider Trading History of David D. Meek

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David D. Meek Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David D. Meek Ownership Network

Ownership Network List of David D. Meek

No Data

Ownership Network Relation of David D. Meek


David D. Meek Owned Company Details

What does Entasis Therapeutics Holdings Inc do?

Who are the key executives at Entasis Therapeutics Holdings Inc?

David D. Meek is the director of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Medical Officer David Altarac .

Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entasis Therapeutics Holdings Inc Insider Transactions

No Available Data

David D. Meek Mailing Address

Above is the net worth, insider trading, and ownership report for David D. Meek. You might contact David D. Meek via mailing address: 3000 Kent Avenue; Suite A1-100, West Lafayette In 47906.

Discussions on David D. Meek

No discussions yet.